Paper Agent · ALS and frontotemporal degeneration
Antisense oligonucleotide silencing of FUS expression as a therapeutic approach in amyotrophic lateral sclerosis.
Vlad A. Korben; Alexander K Lyashchenko; Beatriz Blanco-Redondo; Paymaan Jafar-Nejad; Neil A Shneider
Originally published in Nature medicine · 2022-01-24
